Pipali (Long Pepper) for Immune Function

Research suggests that Pipali (Long Pepper) and its key bioactive compounds — piperine and piperlongumine — exhibit a range of immunomodulatory effects, including suppression of dendritic cell maturation, inhibition of T lymphocyte proliferation, modulation of innate immune responses via NLRP3 inflammasome inhibition, enhancement of CD8+ T cell activity, and reduction of pro-inflammatory mediators such as IL-6. Studies indicate these compounds may also influence immune checkpoint pathways relevant to anti-tumor immunity and show anti-allergic and anti-histaminic properties. The current evidence base consists primarily of in vitro studies, animal models, and narrative reviews, with very limited clinical trial data in humans, meaning findings should be interpreted cautiously and cannot yet be extrapolated to reliable effects in people. While the overall direction of the literature is consistently supportive, key limitations include poor bioavailability of piperine, dose-dependent variability in effects, and the absence of large-scale randomized controlled trials to validate the mechanistic findings observed in laboratory settings.